Cargando…

Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma

This study aimed to identify noninvasive protein markers capable of detecting the presence and prognosis of esophageal squamous-cell carcinoma (ESCC). Analyzing microarray expression data collected from 17-pair ESCC specimens, we identified one protein, matrix metalloproteinase-1 (MMP1), as a possib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yu-Kuei, Tung, Chun-Wei, Lee, Jui-Ying, Hung, Yi-Chun, Lee, Chien-Hung, Chou, Shah-Hwa, Lin, Hung-Shun, Wu, Ming-Tsang, Wu, I-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951749/ https://www.ncbi.nlm.nih.gov/pubmed/27436512 http://dx.doi.org/10.1038/srep30057

Ejemplares similares

Substance Use (Alcohol, Areca Nut and Cigarette) Is Associated with Poor Prognosis of Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2013)

Identification of Biomarkers for Esophageal Squamous Cell Carcinoma Using Feature Selection and Decision Tree Methods
por: Tung, Chun-Wei, et al.
Publicado: (2013)

High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma
por: Wu, I-Chen, et al.
Publicado: (2021)

Polymorphism in COX-2 modifies the inverse association between Helicobacter pylori seropositivity and esophageal squamous cell carcinoma risk in Taiwan: a case control study
por: Hu, Huang-Ming, et al.
Publicado: (2009)

Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes
por: Yu, Tung-Yang, et al.
Publicado: (2013)

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma
por: Mukherjee, Sumana, et al.
Publicado: (2010)

Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics
por: Li, Chien-Chang, et al.
Publicado: (2020)

Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma
por: Tsai, Tsung-You, et al.
Publicado: (2022)

Effect of small interfering RNAs on matrix metalloproteinase 1 expression
por: Chen, Gen-Hung, et al.
Publicado: (2014)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

Overexpression of ATPase Na+/K+ transporting alpha 1 polypeptide, ATP1A1, correlates with clinical diagnosis and progression of esophageal squamous cell carcinoma
por: Wu, I-Chen, et al.
Publicado: (2016)

High Level of Plasma Matrix Metalloproteinase-11 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma
por: Hsin, Chung-Han, et al.
Publicado: (2014)

Increased nasal matrix metalloproteinase-1 and -9 expression in smokers with chronic rhinosinusitis and asthma
por: Huang, Chien-Chia, et al.
Publicado: (2019)

Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2013)

Matrix metalloproteinase‐14 (MMP‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation
por: Chen, Nanzheng, et al.
Publicado: (2020)

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan
por: Chen, Hui-Shan, et al.
Publicado: (2016)

Cardiac Dose Predicts the Response to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma
por: Ho, Yu-Chieh, et al.
Publicado: (2023)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Change in PD-L1 and CD8 Expression after Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
por: Chen, Wei-Chung, et al.
Publicado: (2022)

Endoscopic Surveillance for Metachronous Esophageal Squamous Cell Neoplasms among Head and Neck Cancer Patients
por: Chen, Yi-Hsun, et al.
Publicado: (2020)

Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline
por: Lo, Chun-Yu, et al.
Publicado: (2018)

Long-term survival after pulmonary metastasectomy in patients with esophageal squamous cell carcinoma with lung metastasis
por: Lo, Chien-Ming, et al.
Publicado: (2022)

Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases
por: Tsai, Shih-Hung, et al.
Publicado: (2016)

Endoplasmic Reticulum Stress of Oral Squamous Cell Carcinoma Induces Immunosuppression of Neutrophils
por: Wu, Ching-Fang, et al.
Publicado: (2022)

Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy
por: Ho, Yu-Chieh, et al.
Publicado: (2021)

Comparative Study of Esophageal Stent and Feeding Gastrostomy/Jejunostomy for Tracheoesophageal Fistula Caused by Esophageal Squamous Cell Carcinoma
por: Chen, Yen-Hao, et al.
Publicado: (2012)

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma
por: Yu, Xiang-Yang, et al.
Publicado: (2022)

Matrix metalloproteinase 2 level in human follicular fluid is a reliable marker of human oocyte maturation in in vitro fertilization and intracytoplasmic sperm injection cycles
por: Yang, Wen-Jui, et al.
Publicado: (2015)

Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe
por: Wang, Kuo-Hwa, et al.
Publicado: (2018)

Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression
por: Su, Chun-Wen, et al.
Publicado: (2017)

Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan
por: Hsieh, Meng-Heng, et al.
Publicado: (2013)

Overexpression of carbonic anhydrase IX induces cell motility by activating matrix metalloproteinase-9 in human oral squamous cell carcinoma cells
por: Yang, Jia-Sin, et al.
Publicado: (2017)

Correction: Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe
por: Wang, Kuo-Hwa, et al.
Publicado: (2018)

FDG PET using SUV(max) for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy
por: Huang, Yung-Cheng, et al.
Publicado: (2017)

Do different bariatric surgical procedures influence plasma levels of matrix metalloproteinase-2, -7, and -9 among patients with type 2 diabetes mellitus?
por: Wu, Wen-Chi, et al.
Publicado: (2020)

SIRT1 overexpression is an independent prognosticator for patients with esophageal squamous cell carcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients
por: Chou, Che-Yi, et al.
Publicado: (2021)

Overall Survival for Esophageal Squamous Cell Carcinoma with Multiple Primary Cancers after Curative Esophagectomy—A Retrospective Single-Institution Study
por: Tsai, Ping-Chung, et al.
Publicado: (2022)

Elevated Plasma Matrix Metalloproteinase-9 and Its Correlations with Severity of Disease in Patients with Ventilator-Associated Pneumonia
por: Li, Yia-Ting, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n1chfrpvduh9s3g4noi68idjmm